EMGRAF

Main information

  • Trade name:
  • EMGRAF 10 CAP
  • Dosage:
  • 1MG
  • Pharmaceutical form:
  • CAP
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMGRAF 10 CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

13-10-2017

Pending EC decision:  Tacforius, tacrolimus, Opinion date: 12-Oct-2017

Pending EC decision: Tacforius, tacrolimus, Opinion date: 12-Oct-2017

Europe - EMA - European Medicines Agency

7-3-2018

TACROLIMUS MONOHYDRATE (Tacrolumus Monohydrate) Powder [Attix Pharmaceuticals Inc]

TACROLIMUS MONOHYDRATE (Tacrolumus Monohydrate) Powder [Attix Pharmaceuticals Inc]

Updated Date: Mar 7, 2018 EST

US - DailyMed

12-2-2018

ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Carton Service, Incorporated]

ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Carton Service, Incorporated]

Updated Date: Feb 12, 2018 EST

US - DailyMed

31-1-2018

TACROLIMUS Capsule [A-S Medication Solutions]

TACROLIMUS Capsule [A-S Medication Solutions]

Updated Date: Jan 31, 2018 EST

US - DailyMed

23-1-2018

TACROLIMUS Capsule [Mylan Pharmaceuticals Inc.]

TACROLIMUS Capsule [Mylan Pharmaceuticals Inc.]

Updated Date: Jan 23, 2018 EST

US - DailyMed

19-1-2018

TACROLIMUS Capsule [Cardinal Health]

TACROLIMUS Capsule [Cardinal Health]

Updated Date: Jan 19, 2018 EST

US - DailyMed

16-1-2018

PROTOPIC (Tacrolimus) Ointment [LEO Pharma Inc.]

PROTOPIC (Tacrolimus) Ointment [LEO Pharma Inc.]

Updated Date: Jan 16, 2018 EST

US - DailyMed

19-12-2017

AX PHARMACEUTICAL CORP (Tacrolimus) Powder [AX Pharmaceutical Corp]

AX PHARMACEUTICAL CORP (Tacrolimus) Powder [AX Pharmaceutical Corp]

Updated Date: Dec 19, 2017 EST

US - DailyMed

12-12-2017

Tacforius (Teva B.V.)

Tacforius (Teva B.V.)

Tacforius (Active substance: tacrolimus) - Centralised - Authorisation - Commission Decision (2017)8596 of Tue, 12 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4435

Europe -DG Health and Food Safety

1-12-2017

TACROLIMUS Capsule [American Health Packaging]

TACROLIMUS Capsule [American Health Packaging]

Updated Date: Dec 1, 2017 EST

US - DailyMed

16-11-2017

TACROLIMUS Capsule [Golden State Medical Supply, Inc.]

TACROLIMUS Capsule [Golden State Medical Supply, Inc.]

Updated Date: Nov 16, 2017 EST

US - DailyMed

31-10-2017

TACROLIMUS Ointment [E. Fougera Co. A Division Of Fougera Pharmaceuticals Inc.]

TACROLIMUS Ointment [E. Fougera Co. A Division Of Fougera Pharmaceuticals Inc.]

Updated Date: Oct 31, 2017 EST

US - DailyMed

26-10-2017

TACROLIMUS Capsule [Aphena Pharma Solutions - Tennessee, LLC]

TACROLIMUS Capsule [Aphena Pharma Solutions - Tennessee, LLC]

Updated Date: Oct 26, 2017 EST

US - DailyMed

19-10-2017

ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Veloxis Pharmaceuticals, Inc]

ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Veloxis Pharmaceuticals, Inc]

Updated Date: Oct 19, 2017 EST

US - DailyMed

25-8-2017

EU/3/17/1912 (VIVUS B.V.)

EU/3/17/1912 (VIVUS B.V.)

EU/3/17/1912 (Active substance: Tacrolimus) - Orphan designation - Commission Decision (2017)5921 of Fri, 25 Aug 2017 European Medicines Agency (EMA) procedure number: EMA/OD/099/17

Europe -DG Health and Food Safety

19-7-2017

X (Tacrolimus) Powder [AX Pharmaceutical Corp]

X (Tacrolimus) Powder [AX Pharmaceutical Corp]

Updated Date: Jul 19, 2017 EST

US - DailyMed

13-7-2017

TACROLIMUS Capsule, Gelatin Coated [Panacea Biotec Ltd]

TACROLIMUS Capsule, Gelatin Coated [Panacea Biotec Ltd]

Updated Date: Jul 13, 2017 EST

US - DailyMed